Search

Search Constraints

You searched for: Subject Melanoma--Treatment Remove constraint Subject: Melanoma--Treatment Start Over

Search Results

2. Perspectives in melanoma: meeting report from the “Melanoma Bridge” (December 5th–7th, 2019, Naples, Italy)

5. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

6. Context Sensitive Modeling of Cancer Drug Sensitivity

7. A multi-center study of high dose Aldesleukin (Proleukin® (HD IL-2) + Vemurafenib Zelboraf® ) therapy in patients with BRAFV600 mutation positive metastatic melanoma (proclivity 01)